ATP content of isolated fat cells. Effects of insulin, ouabain, and lipolytic agents.
D000255:Adenosine Triphosphate / Q000032:analysis / Q000378:metabolism*; D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002110:Caffeine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002210:Caprylates / Q000494:pharmacology; D003864:Depression, Chemical; D004837:Epinephrine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D049454:Firefly Luciferin; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D050356:Lipid Metabolism; D008156:Luciferases; D008163:Luminescent Measurements; D008297:Male; D008660:Metabolism / Q000187:drug effects; D051379:Mice; D003012:Microbial Collagenase; D009840:Oligomycins / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology; D011773:Pyruvates / Q000378:metabolism; D012709:Serum Albumin / Q000008:administration & dosage / Q000494:pharmacology; D013268:Stimulation, Chemical; D013997:Time Factors
D002210:Caprylates; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D009840:Oligomycins; D011773:Pyruvates; D012709:Serum Albumin; D002110:Caffeine; D010042:Ouabain; D049454:Firefly Luciferin; D000255:Adenosine Triphosphate; D008156:Luciferases; D003012:Microbial Collagenase; D005947:Glucose; D011188:Potassium; D004837:Epinephrine